← SynDRA
PHENSERINE
SynDRA canonical compound SYN0003210 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | BCHE |
|---|
| Mechanism of action | Acetylcholinesterase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Beta amyloid inhibitor
- Acetylcholinesterase inhibitor
- beta amyloid synthesis inhibitor
- ACHE INHIBITOR
- BCHE INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- ARSA
- ATXN2
- CBX1
- EHMT2
- FAAH
- HDAC6
- MAPT
- NPC1
- RGS4
- SHMT2
- SMN1
- TDP1
- USP1
- VDR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Cholinesterase Inhibitors
Cross-references
Synonyms
- (-)-Phenserine
- (-)-Eseroline phenylcarbamate
- SUE285UG3S
- N-phenylcarbamoyleseroline
- N-phenylcarbamoyl eseroline
- RefChem:861533
- DTXCID001335119
- (+/-)-Phenserine
- Phenserine, (+/-)-
- Phenserine (racemate) [MI]
- N8142NV8UM
- phenserine.tartaric acid
- (-)-N-Phenylcarbamoyleseroline
- UNII-SUE285UG3S
- UNII-N8142NV8UM
- PHENSERINE [MI]
- BUNTANETAP, (-)-
- orb3132238
- SCHEMBL1537384
- SCHEMBL30751020
- BDBM10958
- BUNTANETAP, (+/-)-
- PBHFNBQPZCRWQP-QUCCMNQESA-N
- HMS3261J07
- Tox21_500523
- EX-A11162
- MFCD00672748
- AKOS015967321
- Phenserine, >=98% (HPLC), solid
- CCG-221827
- LP00523
- SDCCGSBI-0633726.P001
- NCGC00163250-01
- NCGC00163250-02
- NCGC00163250-05
- NCGC00261208-01
- DA-76812
Look up PHENSERINE in the interactive SynDRA portal →